Interferon‐expressing oncolytic adenovirus + chemoradiation inhibited pancreatic cancer growth in a hamster model
Cancer Science · 2023
DOI: 10.1111/cas.15903 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, 2023. Verfasst von Shuhei Shinoda und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of Minnesota, Minneapolis, MN, USA. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal, Adenoviridae Infections. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
Past clinical trials of adjuvant therapy combined with interferon (IFN) alpha, fluorouracil, cisplatin, and radiation improved the 5‐year survival rate of pancreatic ductal adenocarcinoma (PDAC). However, these trials also revealed the disadvantages of the systemic toxicity of IFN and insufficient delivery of IFN. To improve efficacy and tolerability, we have developed an oncolytic adenovirus‐expressing IFN (IFN‐OAd). Here, we evaluated IFN‐OAd in combination with chemotherapy (gemcitabine + nab‐paclitaxel) + radiation. Combination index (CI) analysis showed that IFN‐OAd + chemotherapy + radiation was synergistic (CI
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, University of Minnesota, Minneapolis, MN, USA.
- Department of Gastroenterology and Hepatology, Yamaguchi University Graduate school of Medicine, Yamaguchi, Japan.
- Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.
- Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA.
- Institute of Molecular Virology, University of Minnesota, Minneapolis, MN, USA.
ORCID-Profile: Shuhei Shinoda
Förderung
- NCI NIH HHS
- National Cancer Institute
Zitieren
APA
Shinoda, S., Sharma, N. S., Nakamura, N., Inoko, K., Sato-Dahlman, M., Murugan, P., Davydova, J., & Yamamoto, M. (2023). Interferon‐expressing oncolytic adenovirus + chemoradiation inhibited pancreatic cancer growth in a hamster model. Cancer Science. https://doi.org/10.1111/cas.15903
Vancouver
Shinoda S, Sharma NS, Nakamura N, Inoko K, Sato-Dahlman M, Murugan P, et al. Interferon‐expressing oncolytic adenovirus + chemoradiation inhibited pancreatic cancer growth in a hamster model. Cancer Science. 2023. doi:10.1111/cas.15903
BibTeX
@article{Shinoda2023,
author = {Shinoda, Shuhei and Sharma, Nikita S and Nakamura, Naohiko and Inoko, Kazuho and Sato-Dahlman, Mizuho and Murugan, Paari and Davydova, Julia and Yamamoto, Masato},
title = {Interferon‐expressing oncolytic adenovirus + chemoradiation inhibited pancreatic cancer growth in a hamster model},
journal = {Cancer Science},
year = {2023},
doi = {10.1111/cas.15903}
}
EUVIMED